Cargando…
Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma
Background: Liver cancer is a common malignant tumor worldwide, and its morbidity and mortality increase each year. The disease has a short course and high mortality, making it a serious threat to human health. Purpose: The objective of this study was to create novel liver-targeting nanoliposomes to...
Autores principales: | Zhou, Lili, Zou, Manshu, Zhu, Kun, Ning, Shuangcheng, Xia, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749572/ https://www.ncbi.nlm.nih.gov/pubmed/31450608 http://dx.doi.org/10.3390/molecules24173080 |
Ejemplares similares
-
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
por: Xu, Yilin, et al.
Publicado: (2022) -
Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma
por: Zhang, Xue, et al.
Publicado: (2017) -
Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation
por: Zhang, Xue, et al.
Publicado: (2017) -
The disease and gene annotations (DGA): an annotation resource for human disease
por: Peng, Kai, et al.
Publicado: (2013) -
Influence of Oil Status on Membrane-Based Gas–Oil Separation in DGA
por: Chen, Tunan, et al.
Publicado: (2022)